Skip to content

Advertisement

  • Poster presentation
  • Open Access

Intravenous paracetamol (Prodafalgan) causes hypotension in critically ill patients

  • 1,
  • 1,
  • 1 and
  • 1
Critical Care20048 (Suppl 1) :P244

https://doi.org/10.1186/cc2711

  • Published:

Keywords

  • Public Health
  • Blood Pressure
  • Heart Rate
  • Noradrenaline
  • Emergency Medicine

Introduction

Some critically ill patients cannot absorb enteral medications. We noted that intravenous (IV) Prodafalgan (PRDFG), a recently introduced parenteral bioprecursor of paracetamol, caused hypotension. A prospective study was conducted.

Methods

The population was ICU patients requiring IV PRDFG (rectal temperature ≥ 38°C, no enteral route). PRDFG (2 g) was infused over 15–20 min. The temperature, heart rate, systolic/diastolic blood pressure and mean blood pressure (MAP) were recorded before, during and 15–120 min following infusion. Interventions to correct hypotension were recorded.

Results

Seventy-two events, in 14 patients, of PRDFG administration were recorded. MAP dropped significantly 15 min following PRDFG infusion. Initiation or increase of noradrenaline occurred in 25% of the events and fluid bolus was given in 8%.

Conclusions

PRDFG caused significant hypotension, requiring active intervention in 33% of the events. This data substantiated the anecdotal knowledge on the relationship between paracetamol (acetaminophen) and hypotension in the critically ill and associated it with the IV preparation.

Figure 1

Authors’ Affiliations

(1)
Shaare Zedek Medical Centre, Jerusalem, Israel

Copyright

© BioMed Central Ltd. 2004

Advertisement